HomeBiotech

Biotech

IDEAYA Biosciences Announces Positive Interim Phase 2 Data for Darovasertib and Successful FDA Type C Meeting on Registrational Trial Design for Regulatory Approval in Neoadjuvant Uveal Melanoma

IDEAYA Biosciences Announces Positive Interim Phase 2 Data for Darovasertib and Successful FDA Type C Meeting on Registrational Trial Design for Regulatory Approval in Neoadjuvant Uveal Melanoma

September 23, 2024

Antengene Announces XPOVIO® (selinexor) Approved for Commercialization in Thailand

Antengene Announces XPOVIO® (selinexor) Approved for Commercialization in Thailand

September 23, 2024

Preclinical Research with Advanced Oncology Models and Immuno-oncology Services by Altogen Labs

Preclinical Research with Advanced Oncology Models and Immuno-oncology Services by Altogen Labs

September 21, 2024

Henlius Receives Positive CHMP Opinion for HANSIZHUANG as First-Line Treatment for Extensive-Stage Small Cell Lung Cancer

Henlius Receives Positive CHMP Opinion for HANSIZHUANG as First-Line Treatment for Extensive-Stage Small Cell Lung Cancer

September 21, 2024

FDA Roundup: September 20, 2024

FDA Roundup: September 20, 2024

September 21, 2024

Rakuten Medical Presented Research Results of Preclinical Studies for PD-L1-Targeted Photoimmunotherapy at The 83rd Annual Meeting of The Japanese Cancer Association 2024

Rakuten Medical Presented Research Results of Preclinical Studies for PD-L1-Targeted Photoimmunotherapy at The 83rd Annual Meeting of The Japanese Cancer Association 2024

September 20, 2024

UNION therapeutics to present orismilast Phase 2b results in atopic dermatitis as a late-breaking oral presentation at the EADV Congress 2024

UNION therapeutics to present orismilast Phase 2b results in atopic dermatitis as a late-breaking oral presentation at the EADV Congress 2024

September 20, 2024

Renovos Biologics strengthens its Board’s US expertise with the appointment of Lisa Ferrara, Ph.D., as a Non-Executive Director

Renovos Biologics strengthens its Board’s US expertise with the appointment of Lisa Ferrara, Ph.D., as a Non-Executive Director

September 19, 2024

Sirnaomics Announces Demonstration of a Novel Mechanism of Action of Its siRNA Therapeutics for Focal Fat Reduction in Journal of Cosmetic Dermatology

Sirnaomics Announces Demonstration of a Novel Mechanism of Action of Its siRNA Therapeutics for Focal Fat Reduction in Journal of Cosmetic Dermatology

September 19, 2024

TFS HealthScience Unveils Mission to Empower Partners and Enrich Lives Worldwide

TFS HealthScience Unveils Mission to Empower Partners and Enrich Lives Worldwide

September 19, 2024

« 1 … 12 13 14 15 16 … 75 »